PMID
int64 35.7M
36.4M
| Title/Abstract
stringlengths 22
8.78k
| MeshTerms
stringlengths 7
101
| SemanticTypes
stringlengths 4
64
|
|---|---|---|---|
36,335,422
|
clinic characterist cat sensit adult cat ownership cat owner attitud background cat allergen sensit signific risk factor allerg rhiniti asthma insuffici data prefer attitud cat owner cat allergi object investig clinic characterist adult sensit cat associ cat ownership assess owner attitud behavior method studi evalu adult patient age year sensit cat allergen confirm skin prick test demograph clinic data patient obtain retrospect hospit medic record system telephon interview patient conduct evalu whether own cat attitud toward cat allergi total patient could reach telephon refus particip studi exclud patient categor never own cat earli cat ownership cat cat first year patient life past current cat ownership accord status patient time skin prick test current cat owner question whether relinquish cat presenc degre symptom patient relinquish cat patient continu live cat result total patient womenmen mean age includ studi eighti three patient current cat owner skin prick test cat owner continu live cat two third owner symptomat experienc nasal symptom five patient symptom report worsen symptom signific impact symptom determin regard number cat cat breed precautionari measur conclus cat allergen potenti risk public health clinician must engag share decis make type environment chang patient will make treatment option readi accept recogn patient prefer keep cat
|
D010067;D001249
|
T078;T081;T047
|
36,335,421
|
predictor anaphylaxi peanut tree nut mediterranean popul background peanut pn tree nut tn major caus anaphylaxi worldwid aim determin clinic demograph characterist associ anaphylaxi patient sensit pn andor tn mediterranean popul method conduct retrospect studi includ patient allerg pn andor tn allergi symptom plus specif immunoglobulin e sige sensit evalu consult januari decemb univari analysi multivari logist regress model develop includ demograph clinic laboratori data independ variabl anaphylaxi pn andor tn depend variabl result anaphylaxi associ earlier age onset allergi pn cashew andor pistachio pine nut allergi tn allergi gender atop comorbid cofactor associ pn andor tn anaphylaxi anaphylaxi pn cashew andor pistachio pine nut associ reactiv fewer number pn andor tn food although sige sensit lipid transfer protein ltp high preval popul seed storag protein ssp posit associ anaphylaxi pn allergi absenc pathogenesi relat protein famili sensit correl pn hazelnut anaphylaxi higher level sige almond extract predict anaphylaxi level sige pn andor tn extract predict conclus high preval sensit pan allergen ltp seem signific impact pn andor tn allergi sever studi instead factor earli age onset posit ssps seem strong associ anaphylaxi specif pn andor tn find may contribut individu risk assess popul
|
D000707;D021184;D021183
|
T047;T046
|
36,335,420
|
pearl pitfal advers cutan reaction covid vaccin background rash coronavirus diseas covid mrna vaccin occur typic atyp present object goal articl increas awar review various diagnosi manag cutan advers reaction associ covid vaccin allergyimmunolog fellow resid general physician general practition method pertin inform includ patient case review avail literatur use work cite date review complet result case patient cutan advers reaction covid vaccin present follow review cutan reaction covid vaccin conclus provid awar differ rash covid vaccin pearl pitfal diagnosi manag provid
|
D000086382
|
T047;T067
|
36,335,418
|
benralizumab manag rare primari eosinophil lung diseas background eosinophil doubl edg role human bodi essenti import physiolog function whose presenc conspicu varieti diseas character inflamm phenotyp eosinophil exquisit sensit corticosteroid latter recent repres cornerston treatment eosinophil diseas howev patient remain depend oral corticosteroid notabl advers effect burden experi chronic relaps diseas lead high morbid mortal treatment prospect chang advent biolog drug target eosinotrop cytokin interleukin il receptor success latter drug sever eosinophil asthma pave way use rarer eosinophil lung diseas recent mepolizumab human monoclon antibodi work il approv add treatment relaps remit refractori eosinophil granulomatosi polyangi egpa patient age year benralizumab human antibodi bind portion il receptor also test efficaci egpa two clinic trial grow number case report case seri support use steroid spare agent treatment egpa method review summar scientif literatur evalu efficaci benralizumab treatment patient afflict rare primari eosinophil lung diseas result literatur found larg case report report use benralizumab egpa chronic eosinophil pneumonia cep allerg bronchopulmonari aspergillosi abpa often led deplet eosinophil less exacerb decreas system corticosteroid burden advers effect report conclus benralizumab prospect role treatment rare eosinophil lung diseas need elucid random control trial
|
D015267;D014890;D004802;D001249
|
T047
|
36,335,417
|
manag referr pattern new onset chronic cough primari care patient background diagnosi manag chronic cough primari care challeng despit one common chronic condit object clinic character patient new onset chronic cough primari care set method retrospect studi adult patient age year least three visit primari care provid pcp new onset cough least week first third visit within tertiari care center affili clinic januari januari n calcul frequenc primari care visit diagnost test specialist referr prescrib medic month third visit pcp cough result patient met criteria new onset chronic cough four primari care visit relat cough despit receiv referr specialist receiv order chest radiograph evalu chronic cough antibiot system corticosteroid prescrib patient respect prescrib opiat patient prescrib central neuromodul agent angiotensin convert enzym inhibitor discontinu patient take conclus found consider heterogen discrep clinic guidelin recommend patient present new chronic cough substanti unmet need studi chronic cough primari care set inform import stakehold
|
D003371;D012017
|
T184;T058;T170;T097
|
36,335,415
|
curcumin signific affect immedi skin test background curcumin shown decreas allerg symptom biomark anim human studi object studi aim determin curcumin affect immedi skin prick test method enrol particip sensit select antigen particip random treatment curcumin placebo doubl blind fashion particip underw titrat skin prick test week treatment pre posttreat skin test wheal flare compar result curcumin statist signific effect immedi skin prick test wheal flare size conclus although curcumin may attenu allerg symptom biomark signific effect immedi skin prick test result need discontinu test
|
D003474;D014581
|
T121;T047;T130;T109
|
36,335,414
|
predict factor recurr omalizumab cessat elder urticaria real life studi background well defin data help predict recurr risk urticaria omalizumab cessat elder patient chronic spontan urticaria csu object aim evalu effect safeti omalizumab determin possibl predict factor recurr omalizumab cessat elder csu method total patient csu treat omalizumab includ divid two group accord age group age year n group age year n demograph clinic featur immunoglobulin g igg anti thyroid peroxidas antibodi anti tpo serum total ige analyz igg anti tpotot ige ratio calcul pretreat day urticaria activ score medic score urticaria control test result compar treatment period advers effect also evalu result common advers effect omalizumab treatment inject site reaction group omalizumab ceas week group group respect p csu recur omalizumab discontinu patient group group respect p median baselin igg anti tpo higher patient recurr csu group group p group cutoff valu igg anti tpo igg anti tpotot ige ratio iuml recurr respect conclus omalizumab effect safe elder patient csu serum baselin igg anti tpo level igg anti tpotot ige ratio could serv predictor recurr csu omalizumab cessat elder patient
|
D014581;D000080223;D018926
|
T121;T047
|
36,335,413
|
treatment option moder sever atop dermat background treatment chronic refractori moder sever atop dermat ad tradit reli broad spectrum system anti inflammatori agent introduct biolog janus kinas inhibitor jakinib step manag moder sever ad rapid chang howev guidelin yet provid formal recommend best incorpor agent treatment plan object summar updat evid base medic treatment ad includ propos posit biolog jakinib treatment algorithm method literatur search sever medic literatur data base guidelin posit paper systemat review clinic trial treatment moder sever ad conduct prepar narrat review result emolli topic corticosteroid mainstay treat acut flare maintain chronic control second line topic agent includ calcineurin inhibitor eg tacrolimus pimecrolimus crisaborol ruxolitinib acut flare cyclosporin prefer system corticosteroid chronic treatment phototherapi consid system anti inflammatori agent tradit anti inflammatori agent cyclosporin first line choic methotrex azathioprin equal secondari choic although abrocitinib may better efficaci dupilumab base indirect comparison abrocitinib requir closer monitor advers event base packag label jakinib eg abrocitinib upadacitinib use failur system agent includ biolog eg dupilumab tralokinumab biolog jakinib consid tradit system anti inflammatori agent conclus clinician consid modifi step manag ad await develop nation intern guidelin recommend best posit biolog jakinib ad treatment algorithm
|
D003876;D001688
|
T123;T047;T121
|
36,335,412
|
monkeypox viral infect diseas challeng allergist immunologist background human monkeypox zoonosi caus monkeypox virus orthopoxvirus close relat variola virus causat agent smallpox diseas first report central africa continu endem histor affect poorest margin communiti world condit recent attract global attent due case includ five death report world health organ total confirm monkeypox case unit state report center diseas control prevent juli juli world health organ declar current monkeypox outbreak public health emerg intern concern object purpos present report review epidemiolog monkeypox viral infect clinic manifest current recommend diagnosi treatment use vaccin prevent diseas focus aspect particular relev allergistimmunologist result monkeypox discov earli year well describ research west central africa diseas present decad although outbreak thus far most affect men sex men possibl diseas could becom endem could begin spread set close physic contact virus transmit conclus monkeypox differ viral infect coronavirus unlik coronavirus extrem contagi respiratori pathogen monkeypox primarili transmit bodi fluid andor prolong skin skin contact although control monkeypox requir renew effort resourc learn much past tool stop virus becom yet anoth serious ill american contend allergistimmunologist play signific role
|
D045908;D000072339
|
T047;T098
|
36,335,411
|
return mix respiratori bacteri vaccin background oral sublingu administ lysat mix respiratori pathogen bacteria use europ asia part world unit state sinc mid first prevent recurr respiratori tract infect later prevent wheez asthma exacerb associ respiratori infect recent treatment allerg rhiniti appar success treatment contrast negat experi treat inject similar mix respiratori bacteri vaccin mrbv bv prevent asthma exacerb associ respiratori infect common practic abandon year ago method textbook articl use inject bvs prevent asthma exacerb associ respiratori infect review includ number random doubl blind placebo control rdbpc studi result predomin negat contribut abandon treatment also review recent articl europ china report clinic immunolog support use oral sublingu administ mix respiratori bacteri lysat mrbl bl result review five rdbpc studi parenter use bvs prevent asthma exacerb conduct lead intern allergist show combin patient overal reduct asthma attack placebo howev five studi patient oral sublingu treatment bls reduct respiratori infect wheez episod asthma exacerb placebo conclus report result oral sublingu bls far superior histor perform inject bvs possibl reason differ discuss none clear respons differ clinic result
|
D001249;D065631;D012141
|
T047
|
36,335,410
|
posit percept covid vaccin hae signific impact vaccin diseas cours background advers effect coronavirus diseas covid vaccin impact covid vaccin attack hereditari angioedema hae well defin object aim investig influenc covid vaccin cours hae method covid vaccin status determin adult patient hae number sever attack record patient diari evalu four differ period compris month first dose period first second dose covid vaccin patient period second dose third dose receiv three dose month last vaccin dose diseas attack sever assess diseas sever score dss point visual analog scale respect patient divid two main group group least two dose covid vaccin n group vaccin n sinovac biontech approv turkey result mean standard deviat dss signific higher patient experienc attack vaccin within hour versus p long term prophylaxi less common patient increas number attack n versus n p number patient less high school educ higher group n group n p number patient concern trigger vaccin induc hae attack possibl vaccin advers effect higher group n group n conclus seem covid vaccin increas hae attack regardless type vaccin recommend hae activ control covid vaccin patient well inform safeti vaccin
|
D054179;D000086382;D014612
|
T129;T121;T116;T067;T047
|
36,335,408
|
laboratori diagnost human leishmania infect polymeras chain reaction focuss review detect identif method leishmania infect span rang clinic syndrom impact human mani geograph foci primarili world poorest region transmit bite femal sand fli leishmania infect increas human movement due intern travel war well shift vector habitat due climat chang accur diagnosi speci leishmania infect human lead success treatment infect import prevent model intervent program multitud laboratori techniqu detect leishmania develop past decad although mani drawback sever show promis particular molecular method like polymeras chain reaction review provid overview method avail diagnost laboratori tradit techniqu prefer molecular techniqu emphasi polymeras chain reaction base detect type method
|
D007896;D011576;D007891;D010691
|
T047;T204
|
36,335,407
|
high yield product protopanaxadiol sugarcan molass metabol engin saccharomyc cerevisia ginsenosid panax plant deriv triterpenoid wide applic cardiovascular protect immun boost howev saponin content panax plant fair low make time consum unsustain direct extract protopanaxadiol ppd common precursor dammaran type saponin suffici suppli necessari effici synthesi ginsenosid
|
D031786;D036145;D012503
|
T121;T002;T109
|
36,335,406
|
global trend frontier research coronari microvascular dysfunct bibliometr analysi coronari microvascular dysfunct cmd lead caus ischem heart diseas past decad consider progress made respect research cmd present studi summar current research hotspot trend cmd appli bibliometr approach
|
D006333;D017202
|
T047;T046
|
36,335,405
|
genom wide associ studi surviv patient sepsi sepsi sever system inflammatori respons infect accompani organ dysfunct high mortal rate adult intens care unit genet studi identifi gene variant associ develop outcom sepsi focus biolog candid conduct first genom wide associ studi gwas day surviv adult patient sepsi
|
D055106;D018805
|
T063;T047;T046
|
36,335,404
|
covid pandem affect nurs student career self efficaci profession call mediat impact profession ident profession call pc crucial ascertain profession goal fulfil career choic nurs student thus understand anteced help school improv pc among nurs student critic studi aim explor whether profession ident pi crucial anteced pc act intermediari career self efficaci cse profession call covid pandem
|
D013338;D000086382
|
T047;T067;T097
|
36,335,403
|
detail statist analysi plan randomis control trial effect modifi muscl spare posterior techniqu spair hip hemiarthroplasti displac intracapsular fractur post oper function compar standard later approach hemispair hemispair trial conduct determin whether modifi muscl spare techniqu spair save piriformi internus repair externus hip hemiarthroplasti bring clinic benefit compar standard later techniqu adult age year older displac intracapsular hip fractur articl describ detail statist analysi plan trial method design hemispair definit pragmat superior multicentr randomis control trial intern pilot two parallel group particip ward staff research staff involv post oper assess blind alloc articl describ detail primari secondari outcom statist analysi principl includ survivor averag causal effect sace method chosen specif address issu potenti bias differenti surviv trial arm seen data review trial steer committe particip includ analysi covari includ analysi result present plan main analysi primari outcom plan analys secondari outcom plan addit analys primari secondari outcom
|
D062785;D006620;D019644
|
T061;T037
|
36,335,402
|
clinic applic custom print porous tantalum scaffold combin masquelet induc membran techniqu reconstruct infect segment femor defect studi main exam novel treatment infect segment femor defect combin print porous tantalum prosthesi masquelet induc membran techniqu reconstruct bone defect discuss clinic effect
|
D013635;D005269
|
T196;T023
|
36,335,401
|
qualiti accuraci gastric cancer relat video social media video platform gastric cancer major public health problem worldwid social media affect public daili live way one ever thought possibl tikotok chines version douyin popular short video post platform studi aim evalu qualiti accuraci complet video gastric cancer tiktok douyin
|
D061108;D009369
|
T170;T191
|
36,335,399
|
irisin protect obes relat chronic kidney diseas regul periren adipos tissu function obes mice compar typic viscer fat deposit obes metabol syndrom periren adipos tissu prat dysfunct close link obes relat chronic kidney diseas ob ckd myokin irisin report promot posit outcom metabol diseas studi investig whether irisin could reduc urinari albumin excret demonstr renoprotect effect regul prat function obes mice
|
D005353;D051436
|
T123;T047;T116
|
36,335,398
|
numer morpholog studi african lion panthera leo leo pector limb import appendicular skeleton conform shape physiolog wild anim especi carnivor adapt surviv overemphas limit obsolet inform bone forelimb necessit studi matur adult african lion male femal weigh kg kg obtain differ time post mortem examin carcass bone prepar achiev via cold water macer proper skin muscl remov barest minimum
|
D008045
|
T015
|
36,335,397
|
deciph impact genet variat human polyadenyl use apar end process cleavag polyadenyl import fine tune regulatori process mrna matur numer genet variant known caus contribut human disord disrupt cis regulatori code polyadenyl signal yet due complex code variant interpret remain challeng
|
D026723;D000067877
|
T044;T048
|
36,335,396
|
safe effect shelf immunotherapi base carcd nk cell treatment acut myeloid leukaemia paediatr acut myeloid leukaemia aml character poor outcom patient relapsedrefractori diseas despit improv intens standard therapi leukaem cell paediatr aml patient show high express cd antigen find provid biolog basi target cd chimer antigen receptor car howev carcd therapi aml hamper target tumour toxic long vein vein time
|
D000076962;D015470
|
T129;T191;T116;T192
|
36,335,395
|
compar analysi anticoagul activ immunogen hsc hsc tkd haemaphysali flava haemaphysali flava hematophag ectoparasit acquir nutrit need develop reproduct suck blood digest blood meal blood suck blood meal digest prevent blood coagul import tick previous studi shown heat shock cognat hsc protein certain anticoagul activ immunogen remain unclear also whether mutat individu base tkd like peptid hsc overlap extens method chang anticoagul activ immunogen remain investig
|
D015847;D026863
|
T129;T121;T116;T204
|
36,335,394
|
emigr social econom determin health low incom urban zimbabw negat consequ medic profession emigr health system nation well document literatur howev dearth evid impact emigr general send household welfar health particular studi compar socio econom characterist includ health emigr household non emigr household urban set harar zimbabw
|
D004641;D011203
|
T098;T055;T102;T064;T052
|
36,335,393
|
comparison clinic radiolog outcom three differ surgic treatment resist calcifi tendin shoulder short term random control trial prefer surgic treatment patient conserv therapi resist calcifi tendin shoulder still matter debat therefor purpos studi evalu compar short term clinic radiolog result three surgic treatment option patient
|
D019534;D052256;D002114
|
T047;T046
|
36,335,392
|
calcan osteotomi due insert calcan tendinopathi preoper plan dorsal close wedg calcan osteotomi dcwco indic patient insert tendinopathi calcan achill tendon chauveaus liet cl angl repres differ angl vertic morpholog angl calcaneus cl angl purpos studi assess whether dcwco affect chauveaus liet angl
|
D002111;D052256;D000125
|
T023;T047
|
36,335,391
|
determin critic concentr drug suscept test mycobacterium tuberculosi para aminosalicyl acid clinic isol thya folc dfra mutat accur determin antimicrobi resist profil great import formul optim regimen multidrug resist tuberculosi mdr tb although para aminosalicyl acid pas wide use clinic reliabl test method pas suscept establish herein aim establish critic test concentr pas mycobacteri growth indic tube mgit laboratori set
|
D009169;D010131;D018088
|
T121;T007;T116;T109;T047
|
36,335,390
|
acut hepat unknown aetiolog among children around world august number case acut hepat unknown etiolog ahua drastic increas distribut countri fulfil world health organ definit sever hypothes caus ahua propos investig around world recent unit kingdom uk report human adenovirus hadv adeno associ virus aav co infect lead hypothesi howev still limit evid establish causal relationship ahua potenti aetiolog lead aetiolog continu hadv infect report hadv genom unusu among popul uk especi among auha case expand surveil hadv aav popul environ countri auha case suggest primari action metagenom use detect infecti pathogen larger scale supplement detect virus blood stool liver specimen auha case use develop consensus specif case definit ahua better understand characterist case global base collect case
|
D000258;D000260;D006505
|
T047;T005
|
36,335,388
|
hospit prepar low dose atropin eye drop myopia progress control use atropin sulfat inject dilut normal salin lubric low dose atropin eye drop myopia progress control prepar hous dilut commerci atropin eye drop steril water normal salin common practic wherea atropin inject readili avail could feasibl altern studi aim assess properti hous low dose atropin eye drop prepar dilut atropin inject two solvent test two temperatur condit
|
D001285;D009216
|
T121;T047;T109
|
36,335,387
|
ophthalm arteri chang type diabet without acut coronari syndrom ocular blood flow provid new perspect studi effect diabet ischem heart diseas system blood flow patholog mechan prognosi previous studi analyz hemodynam chang ophthalm arteri oa patient diabet ischem heart diseas result remain controversi due limit observ method aim explor morpholog hemodynam featur oa patient type diabet td without acut coronari syndrom ac
|
D054058;D003924;D003324
|
T047
|
36,335,385
|
establish earli diagnosi model cervic precancer lesion use larg scale cervic cancer screen dataset human papilloma virus hpv dna test appli cervic cancer screen effect cancer prevent strategi viral load hpv generat differ assay attract increas attent potenti valu diseas diagnosi progress discoveri
|
D002583;D018290;D030361;D011230
|
T047;T191
|
36,335,383
|
diagnosi treatment right ventricular dysfunct patient covid veno venous extra corpor membran oxygen veno venous vv extracorpor membran oxygen ecmo effect high resourc intens salvag treatment option covid patient acut respiratori distress syndrom ard right ventricular rv dysfunct known sequela covid induc ard yet pauciti data incid determin rv dysfunct vv ecmo retrospect examin determin factor lead rv failur mean earli identif phenomenon patient vv ecmo
|
D015199;D018497;D000086382;D012128
|
T061;T047;T046;T067
|
36,335,382
|
aldh gene polymorph associ fit elder japanes popul aldehyd dehydrogenas aldh rs polymorph exclus asian popul relat mani diseas high reactiv oxygen speci product mitochondria low muscl strength athlet non athlet observ previous studi demonstr purpos research investig influenc aldh rs loss muscl strength age replic previous studi non athlet
|
D011110;D044466
|
T045;T098
|
36,335,381
|
low barrier medic opioid use disord feder qualifi health center retrospect cohort studi medic opioid use disord moud reduc mortal patient access moud feder qualifi health center fqhc implement low barrier model moud includ day moud initi harm reduct philosophi
|
D002047;D009293
|
T121;T048;T109
|
36,335,379
|
covid relat manuscript lag preprint public preprint promin role swift scientif respons covid two year pandem investig much preprint contribut time data share analyz lag time preprint post journal public
|
D000086382
|
T047;T067
|
36,335,378
|
malign testicular unclassifi sex cord stromal tumor case report testicular tumor germ cell tumor sex cord stromal tumor infrequ account testicular tumor unclassifi sex cord stromal tumor extrem rare general sex cord stromal tumor malign report case malign unclassifi sex cord stromal tumor retroperiton lymph node metastasi first visit correspond literatur review
|
D013736;D018312;D009373
|
T191
|
36,335,376
|
optim tobacco treatment deliveri peopl hiv trial protocol random control trial advanc antiretrovir therapi peopl hiv pwh live longer less like die aid relat complic yet prior research shown smoke often address context hiv care individu offer cessat treatment optim tobacco treatment deliveri pwh may increas engag evid base treatment success quit attempt
|
D016540;D014029
|
T055;T048
|
36,335,375
|
chemotherapi induc ace express breast cancer via ros akt hif signal pathway potenti prognost marker breast cancer patient receiv chemotherapi angiotensin convert enzym ace key enzym renin angiotensin system well known function receptor entri sever acut respiratori syndrom coronavirus sar cov host cell covid pandem brought ace spotlight ace express tumor relationship sar cov infect prognosi cancer patient receiv extens attent howev associ ace express tumor therapi prognosi especi breast cancer remain ambigu requir investig previous report ace elev drug resist breast cancer cell exact function ace drug resist progress malign diseas explor
|
D001943;D000086382
|
T047;T191;T067
|
36,335,374
|
chines patient respons doctor patient relationship stimuli evid event relat potenti studi improv medic technolog doctor patient relationship improv howev disput doctor patient increas two group frequent hurt therefor sought explor percept chines patient regard stimuli doctor patient relationship differ valenc
|
D004569;D004644
|
T060;T034;T041
|
36,335,372
|
partial otubain defici compromis fetal well allogen pregnanc despit major chang dendrit cell cell compart pregnanc character well defin immunolog adapt within matern immun cell compart allow surviv genet dispar individu matern womb phenotyp function immun cell larg determin intracellular process extern stimuli ubiquitin deubiquitin enzym known critic regul immun signal either modul stabil interact signal molecul accord absent critic physiolog process may perturb fetal toler induct base previous find mice hemizyg deubiquitin enzym otubain otub give rise homozyg progeni investig whether partial otub defici influenc fetal wellb syngen allogen pregnanc context accompani chang dendrit cell dc cell compart
|
D000072017;D018380
|
T061;T126;T116
|
36,335,371
|
irradi induc exosom hmgb confer radioresist via pikaktfoxoa signal pathway escc radioresist major caus treatment failur esophag squamous cell carcinoma escc radiotherapi under mechan radioresist still unclear irradi ir stimul chang tumor deriv exosom content taken recipi cell play import role prolifer cell cycl apoptosi recipi cell studi investig effect ir induc exosom high mobil group box hmgb radioresist escc cell
|
D000077277;D004938;D024243
|
T123;T191;T116
|
36,335,370
|
associ sleep habit behavior problem earli adolesc descript studi sleep habit relat children behavior emot cognit function strong relationship exist sleep habit behavior problem howev precis sleep habit associ behavior problem remain unclear therefor purpos studi clarifi relationship sleep habit behavior problem earli adolesc
|
D000066553;D012893
|
T033;T047;T048
|
36,335,369
|
addit dydrogesteron treatment chronic endometr treat antibiot premenopaus women endometri polyp retrospect cohort studi assess efficaci dysdrogesteron treatment chronic endometr ce treat antibiot premenopaus women endometri polyp ep
|
D004716;D011127;D014594
|
T047;T191;T190
|
36,335,368
|
anthocyanin improv kidney function diabet kidney diseas regul amino acid metabol diabet kidney diseas dkd among import caus chronic kidney diseas anthocyanin ant polyphenol compound present various food play import role amelior hyperglycemia insulin sensit howev effect ant dkd still poor understood studi aim investig effect ant cyanidin glucosid cg renal function dkd whether anti dkd effect ant relat metabol pathway
|
D003928;D003920
|
T047
|
36,335,365
|
origin methylglutaryl moieti caprazamycin biosynthesi caprazamycin liponucleosid antibiot show bioactiv gram posit bacteria includ clinic relev mycobacterium tuberculosi target bacteri mray translocas chemic structur contain uniqu methylglutaryl moieti share close relat liposidomycin although biosynthesi caprazamycin understood extent origin methylglutaryl coa caprazamycin biosynthesi remain elus
|
D048372;D009169
|
T007
|
36,335,364
|
questionnair lgbm model assess health literaci level mongolian china difficult accur assess health literaci hl level mongolian use chines convent hl questionnair due particular languag cultur live environ therefor import design exclus hl questionnair addit exist statist model meet requir hl assess high precis necessari studi new hl assess model
|
D057220
|
T041
|
36,335,363
|
participatori develop practic afford insecticid treat mosquito proof rang hous design rural southern tanzania insecticid mosquito proof net screen could combin best featur insecticid treat net itn indoor residu spray ir two import front line vector control intervent africa today also overcom import limit method studi engag member rural tanzanian communiti develop evalu simpl afford scalabl procedur instal readili avail screen materi eav gap window hous treat screen wide use ir formul organophosph insecticid pirimipho methyl pm
|
D007306;D000852;D008288;D057148
|
T131;T047;T074;T204
|
36,335,362
|
engin cupriavidus necat h enhanc lithoautotroph poli hydroxybutyr product co repres hydrogen oxid bacterium cupriavidus necat h attract much attent host recycl carbon dioxid co biodegrad polym poli r hydroxybutyr phb although c necat h use model phb produc phb product rate co still low commerci
|
D020118
|
T007
|
36,335,361
|
impact price transpar competit hospit cost research payer claim databas public report consid effect reduc health care cost mitig inform asymmetri market payer incorpor public avail inform mandat pay perform program valu base purchas therefor hospit face increas pressur provid price transpar despit widespread promot healthcar transpar effect public report yet suffici understood studi analyz impact transpar polici competit hospit cost take state oper payer claim databas apcd case interest
|
D012052;D017721
|
T081;T170
|
36,335,360
|
scope review regen medicin medic educ stem cell therapeut regen medicin taken strong foothold biomedicin howev physician current adequ prepar identifi refer deliv safe regen therapi understand gap sought character publish literatur current physician train regen medicin scope review describ current train strategi bridg gap integr educ medic curricula adequ train
|
D004501;D010820
|
T065;T097
|
36,335,359
|
exosom load ultrasmal pt nanoparticl novel low toxic altern cisplatin platinum nanoparticl demonstr excel anticanc properti howev lack specif must deliv tumor amount suffici reach desir therapeut object interest exosom consid excel natur select deliveri nanotool know target properti combin anticanc properti platinum nanoparticl
|
D055354;D053768;D053758;D009369
|
T026;T191;T073
|
36,335,357
|
qualit studi caus circumst drown uganda drown serious worldwid prevent injuri problem especi low middl incom countri lmic aim paper draw result semi structur interview wit famili member friend person involv fatal nonfat drown incid describ circumst drown lakesid non lakesid district identifi potenti contextu appropri intervent drown prevent surveil uganda
|
D004332
|
T037
|
36,335,356
|
sox activ stat promot pancreat cancer progress via regul sox pancreat cancer pc high malign tumor threaten human health long non code rnas lncrnas implic mani cancer includ pc mechan pc yet entir clarifi focus reveal potenti function lncrna sox pc
|
D062085;D010190;D035683
|
T123;T191;T114
|
36,335,355
|
new effici meta ferment process lactic acid product municip solid wast global market lactic acid wit growth back increas applic lactic acid manufactur polylact acid inde lactic acid market expect reach billion us dollar new concept meta ferment propos recent year altern ferment pure cultur due multipl advantag lower suscept contamin need steril cultur media lower raw materi cost howev still challeng overcom increas convers effici decreas format product facilit ferment control context purpos studi develop robust meta ferment process effici produc lactic acid ofmsw stabl pre industri scale l maxim lactic acid product oper condit ph hrt modifi novel bioaugment strategi test
|
D062611;D019149
|
T074;T167
|
36,335,354
|
adolesc pregnanc time covid implic sexual reproduct health right global covid pandem aggrav pre exist challeng associ adolesc sexual reproduct health right srhr evolv evid suggest could advers impact progress made toward improv sexual reproduct health outcom among young peopl pandem stall achiev reduc adolesc pregnanc child marriag reinforc contextu structur determin reproduct health outcom especi among girl pandem increas disrupt school decreas access sexual reproduct health servic compound pre exist socio econom vulner consequ neglect adolesc sexual reproduct health servic past year focus covid continu emerg commentari argu target respons approach adolesc srhr tackl prevent consequ result inequ face adolesc global particular girl
|
D011253;D000086382;D000074384
|
T032;T067;T040;T033;T047
|
36,335,353
|
distribut concord pd l express routin c assay east asian patient non small cell lung cancer current program death ligand pd l express wide appli clinic trial real world clinic practic major biomark efficaci immun checkpoint inhibitor purpos studi reveal distribut concord pd l express larg scale consecut cohort east asian patient non small cell lung cancer nsclc
|
D002289;D008175
|
T191
|
36,335,352
|
synerget deliveri artesun isosorbid mononitr reduct sensit polym nanoparticl ovarian cancer chemotherapi ovarian cancer high fatal gynecolog malign worldwid chemotherapi remain primari modal primari mainten treatment ovarian cancer howev progress develop chemotherapeut agent ovarian cancer slow past year thus new effect chemotherapeut drug urgent need ovarian cancer treatment reduct respons synerget deliveri strategi pssp art ismn co deliveri artesun isosorbid mononitr investig research studi pssp art ismn various effect tumor cell induc product reactiv oxygen speci ros contribut mitochondri damag ii provid nitric oxid ros tumor cell react generat high toxic reactiv nitrogen speci rns caus dna damag iii arrest cell cycl gg phase induc apoptosi pssp art ismn also demonstr excel antitumor activ good biocompat vivo taken togeth result work provid potenti deliveri strategi chemotherapi ovarian cancer
|
D010051;D053758
|
T191;T073
|
36,335,351
|
serpin load extracellular vesicl promot tissu repair mous model impair wound heal chronic metabol diseas diabet character delay wound heal dysregul inflammatori phase wound repair studi focus chang payload extracellular vesicl ev communic immun cell stromal cell wound bed regul rate wound closur adopt transfer ev genet defin mous model use demonstr function molecular basi differ pro repar biolog activ diabet dbdb vs wildtyp ev wound heal identifi sever member serpin famili serin proteas inhibitor absent dbdb ev overexpress serpin f g ev evalu effect wound heal dbdb mice serpin import role regul level elastas plasmin complement factor coordin immun cell signal full thick wound diabet model establish novel therapeut approach engin payload ev base proteom analysi serpin load ev use rescu serpin defici identifi proteom promot wound heal dbdb mice well evalu ev affect extracellular matrix remodel resolut tissu injuri therefor propos identif ev payload downregul diabet wound systemat analyz function activ potenti therapeut base whether express engin ev restor normal kinet tissu repair chronic wound
|
D015843;D000067128;D003920
|
T026;T123;T121;T116;T047
|
36,335,350
|
comparison surgic efficaci lock plate interlock intramedullari nail treatment proxim humerus fractur object studi evalu efficaci lock plate versus interlock intramedullari nail treatment proxim humerus fractur provid clinic data support theoret guidanc
|
D012784;D005594
|
T061;T037
|
36,335,349
|
target oumptprz silenc synerget cdtenhanc chemic therapi toward uveal melanoma base dual modal imag guid manganes metal organ framework nanoparticl metastasi chemic resist serious problem treatment high aggress uveal melanoma um newli identifi lncrna oum overexpress um function catalyst regul protein tyrosin phosphatas ptp activ bind ptp receptor type z ptprz play import role cell prolifer metastasi chemotherapi resist um microenviron henc sirna select knock lncrna oum sioum target gene ptprz siptprz design inhibit oumptprz pathway reduc ptp activ reduct activ interrupt protein tyrosin phosphoryl suppress um prolifer metastasi improv cisplatin sensit um cell overcom limit difficulti drug administr tradit therapeut indocyanin green icg label manganes metal organ framework mof nanoparticl nps fabric link arginin glycin aspart rgd peptid carri sioumsiptprz cisplatin achiev target sirna interfer mediat therapi enhanc cisplatin therapi chemodynam therapi np system also dual modal imag abil icg near infrar region fluoresc dye manganes potenti use magnet reson imag studi verifi signific newli discov lncrna oum new therapeut target aggress um provid drug deliveri np system precis treatment um accompani dual modal imag abil
|
D000073396;D062085;D053758
|
T123;T073;T114;T109
|
36,335,348
|
specif triacylglycerol diacylglycerol lyso phosphatidylcholin speci predict type diabet year prospect studi chines bioactiv lipid play import role insulin secret sensit contribut pathophysiolog type diabet td studi aim identifi novel lipid speci associ incid td nest case control studi within long term prospect chines communiti base cohort median follow year
|
D003924;D011236
|
T047
|
36,335,347
|
direct anterior versus posteriorlater approach clinic outcom total hip arthroplasti treatment sever ddh total hip arthroplasti tha gain popular treatment sever development dysplasia hip ddh posterior later approach pla good clinic efficaci confirm major clinician nevertheless controversi exist regard longer term benefit direct anterior approach daa object studi investig clinic efficaci placement rom prosthesi treatment sever ddh total hip arthroplasti tha differ surgic approach
|
D019644;D006622
|
T061;T074
|
36,335,346
|
synergist effect chronic kidney diseas neuropathi retinopathi caus mortal type type diabet year longitudin studi prognost valu common frequent associ diabet microvascular complic mvc name chronic kidney diseas ckd cardiac autonom neuropathi peripher neuropathi dpn retinopathi dr well establish howev impact differ combin long term mortal adequ assess
|
D003924;D003922;D051436;D003929;D003930;D012164
|
T047
|
36,335,345
|
review user need drive develop lower limb prosthes develop bionic leg seen substanti improv past year peopl lower limb amput still suffer impair mobil eg alter balanc gait control due signific limit contemporari prosthes approach problem human center perspect focus user specif need allow identifi critic improv increas qualiti life sever review user need regard upper limb prosthes comprehens summari need affect lower limb loss exist
|
D000674;D001186
|
T074;T101
|
36,335,344
|
evalu women accept treatment incomplet second trimest abort use misoprostol provid midwiv compar physician mix method studi studi evalu task share postabort care main focus women first trimest mani lack qualit compon aim evalu patient accept treatment incomplet second trimest abort use misoprostol provid midwiv compar physician also gain deeper understand patient live treatment experi uganda
|
D016595;D000027;D008880;D000020;D000028;D010820
|
T061;T121;T091;T109;T093;T033;T097;T081;T046
|
36,335,343
|
construct valid occup mechan job exposur index base five norwegian nationwid survey live condit work environ overal aim studi examin essenti aspect reliabl valid construct occup mechan job exposur index use analys norwegian regist data method util data norwegian nationwid survey live condit work environ occup classifi digit level base norwegian version intern standard classif occup isco construct digit correspond tabl occup code use survey styrk code use styrk mechan exposur collect statist norway use telephon interview reliabl examin agreement individu occup base mechan exposur use cohen kappa sensit specif measur construct concurr predict valid pertain occup mechan job exposur index analys use survey data nationwid regist data
|
D012924;D016273
|
T078;T037;T080
|
36,335,342
|
year retrospect clinic review iatrogen ureter injuri repair resourc depriv set seventi percent ureter injuri result iatrogen caus diagnos postop period may fatal complic sepsi renal function damag increas morbid treatment cost
|
D014513;D000007
|
T023;T037
|
36,335,341
|
associ dental agenesi delay dental develop preliminari studi spanish paediatr popul relat dental anomali pattern dap associ dental anomali studi give rise concept dental anomali pattern dap tooth agenesi associ alter molar infracclus taurodont delay dental develop aim studi evalu dental develop pattern patient non syndrom dental agenesi comparison control group
|
D000848;D014071;D014070
|
T019;T023;T190
|
36,335,340
|
prospect associ circul thrombospondin level heart failur hospit left ventricular remodel diastol function type diabet circul thrombospondin tsp level associ develop heart failur hf recent studi howev studi includ minor patient type diabet associ increas hf risk hyperglycemia induc tsp express tissu express increas type diabet investig prospect associ circul tsp incid hf hospit hhf associ longitudin chang echocardiograph paramet type diabet
|
D003924;D000077203;D006333
|
T121;T047;T046;T109
|
36,335,339
|
effect rough acid medium wear behavior dental resin composit aim studi investig whether citric acid rough surfac synergist effect lead sever wear behavior resin composit
|
D003188;D014867
|
T121;T122;T197
|
36,335,338
|
insight carbapenem resist virul acinetobact baumannii children medic centr eastern china carbapenem resist acinetobact baumannii crab appear frequent children caus great threat global public health urgent investig carbapenem resist virul crab clinician choos appropri antibiot retrospect studi nondupl crab isol conduct carbapenem resist virul gene character polymeras chain reaction pcr gel electrophoresi present studi baumannii main came intens care unit most isol sputum sampl carbapenem resist rate baumannii increas signific compar isol carbapenem resist gene high resist varieti antibiot relat sensit fluoroquinolon tetracyclin blavim blaoxa detect isol wherea blaoxa blaimp blandm present isol respect notabl isol baumannii identifi multidrug resist baumannii mdr ab extens drug resist xdr isol also detect virul gene present isol includ gene iron acquisit system basj secret system ompa plcd quorum sens system abai biofilm format csua adeh pgaa ptk present isol respect crab preval east china carri larg number drug resist virul gene fluoroquinolon tetracyclin may effect antibiot treatment crab infect children depth understand resist virul crab conduc time guid empir drug use control infect
|
D040981;D000151
|
T047;T007
|
36,335,337
|
lymphat metastasi associ circrnamirnamrna network explor pathogenesi therapeut target tripl negat breast cancer base whole transcriptom sequenc analysi experiment verif studi metastat mechan axillari lymph node aln tripl negat breast cancer tnbc remain unclear aim identifi potenti circrna regulatori network aln metastasi
|
D064726;D035683
|
T123;T191;T114
|
36,335,336
|
correl two occlus analyz measur bite forc occlus forc repres masticatori function use quantifi occlus indic provid object occlus forc evalu recent dental practic digit method dental prescal ii dp gc corp tokyo japan scan scan iii v tekscan inc common use clinic evalu treatment outcom scan provid relat bite forc compar maxim bite forc individu teeth unilater arch dp quantifi occlus forc measur newton n half arch overal bite difficult identifi bite forc individu tooth difficult select devic fulfil requir record occlus forc studi aim investig associ bite measur dps scan determin whether measur bite forc compar calcul
|
D001732;D014070
|
T023;T169
|
36,335,335
|
end life experi peopl live socio econom depriv develop world integr review experienc socioeconom depriv poorer qualiti health throughout life cours result poorer qualiti death decreas access palliat care servic greater use acut care reduc access prefer place care compar patient less depriv popul
|
D013727;D017051
|
T058;T093
|
36,335,334
|
reliabl valid veteran administr mobil screen solut tool veteran administr va mobil screen solut tool va msst develop screen patient safe mobil level moment provid clinic decis support relat use safe patient handl mobil sphm equip evid base flowchart tool common languag tool enabl healthcar worker time accur measur communic patient mobil transfer equip need across disciplin set
|
D051346;D059825
|
T033;T184;T097
|
36,335,333
|
willing pay hpv vaccin among femal health care worker chines nationwid survey payment method human papillomavirus hpv vaccin could substanti influenc vaccin behavior china hpv vaccin uptak remain current low studi aim determin willing pay wtp hpv vaccin among chines femal health care worker differ payment scenario
|
D053918;D030361
|
T129;T047;T121;T116
|
36,335,332
|
philosoph foundat health univers health coverag constitut call health univers health coverag call ultim express fair howev alway clear health system move toward equiti prioritis need worst direct resourc marginalis group marginalis individu articl provid overview philosoph underpin health equiti proportion univers highlight trade off involv operationalis core tenant global health practic
|
D019472;D000069576
|
T078;T080
|
36,335,331
|
role iron metabol chronic diseas relat obes obes one major public health problem threaten world well potenti risk factor chronic metabol diseas grow evid iron metabol alter obes peopl howev high refin regul iron metabol obes obes relat complic still investig iron accumul affect bodi sensit insulin type diabet liver diseas cardiovascular diseas review summar chang potenti mechan iron metabol sever chronic diseas relat obes provid new clue futur research
|
D003924;D008107
|
T033;T047
|
36,335,330
|
long term complet respons small cell bladder carcinoma treat carboplatin etoposid atezolizumab small cell bladder carcinoma scbc rare aggress malign tumor establish treatment guidelin treatment algorithm base small cell lung cancer sclc guidelin metastat scbc poor prognosi even treat platinum base chemotherapi usual use extens diseas sclc
|
D018288;D001749;D008175
|
T191
|
36,335,329
|
high level solubl rage associ greater risk mortal covid patient treat dexamethason blood level solubl receptor advanc glycat end product srage acut elev host inflammatori respons infect predict mortal covid howev prognost perform biomark context treatment reduc inflamm unclear studi investig associ srage mortal dexamethason treat covid patient studi sar cov posit subject control attend emerg depart univers teach hospit second wave covid measur srage admiss posit individu srage increas diseas sever correl nation earli warn score pearson r p pgml low srage p higher srage level associ increas risk death adjust relev covari contrast il predict mortal patient result demonstr srage remain independ predictor mortal among covid patient treat dexamethason determin srage could use clinic manag patient popul
|
D000086382
|
T047;T067
|
36,335,328
|
analysi risk factor relat extrem preterm birth retrospect studi preterm birth one main caus perinat morbid mortal impos heavi burden famili societi aim studi identifi risk factor analyz birth condit complic newborn born gestat week extrem preterm ep preterm vp birth clinic extend gestat period
|
D001997;D005322;D007232;D047928;D018805
|
T047;T046
|
36,335,327
|
biomechan analysi stress around tilt implant differ cantilev length concept mani clinic studi report high success rate concept present studi aim compar stress distribut differ tilt distal implant cantilev length system use two dimension photoelast method establish implant photoelast model comput aid design cad rapid prototyp rp method data human edentul mandibl acquir comput tomographi ct three human edentul mandibl implant model differ distal inclin implant hole fabric use mimic geomag studio softwar light solidifi fast shape machin final photoelast model establish tradit method three model four nobelspeedi replac implant interforamin region two posterior implant place degre distal mental foramen four implant splint wrought cobalt chromium alloy framework three photoelast model submit n vertic load five point framework central fossa mandibular first molar mm mm mm mm cantilev length stress produc model photograph digit camera highest valu stress fring pattern record
|
D019094;D015921
|
T074
|
36,335,326
|
network meta analysi effect finerenon versus sglt inhibitor glp receptor agonist cardiovascular renal outcom patient type diabet mellitus chronic kidney diseas evalu cardiovascular renal benefit finerenon sodium glucos cotransport inhibitor sglti glucagonlik peptid receptor agonist glp ra patient type diabet mellitus tdm chronic kidney diseas ckd network meta analysi
|
D000077203;D002318;D003924;D051436
|
T121;T047;T109
|
36,335,325
|
patient report function outcom measur treatment choic prostat cancer aim studi describ chang patient report function outcom measur prom compar pre treatment month radic prostatectomi rp extern beam radiat therapi ebrt brachytherapi activ surveil
|
D011471;D001918
|
T061;T191
|
36,335,324
|
hepat b c human immunodefici virus knowledg among general greek popul result hprolipsi nationwid survey although sever studi hepat b hbv c hcv human immunodefici virus hiv infect conduct greec littl known knowledg level greek popul toward three infect aim assess knowledg level adult greek general popul hbv hcv hiv
|
D006509;D015658;D006526
|
T047
|
36,335,323
|
improv adher test treat track malaria strategi among counter medicin seller otcm intervent implement select rural communiti fanteakwa north district ghana prompt diagnosi treatment malaria prevent mild case develop sever diseas death unfortun parasitolog test febril children greater public formal privat sector inform privat sector mani patient malaria like symptom first seek treatment studi aim improv implement polici among otcm use intervent could scale easili nation level
|
D008288;D000962
|
T121;T047
|
36,335,321
|
model optim vitro percentag speed callus induct carrot via multilay perceptron singl point discret ga radial basi function callus induct first step optim plant regener fit embryogenesi shoot reli callus induct addit use artifici intellig model combin algorithm help optim vitro cultur present studi aim evalu percentag speed callus induct optim carrot multilay perceptron singl point discret genet algorithm ga
|
D018552
|
T168;T002
|
36,335,320
|
anti pd associ immun relat advers event harbing favor clinic prognosi patient gastric cancer immun checkpoint inhibitor ici shown remark benefit treatment rang cancer type although may initi immun relat advers event ira patient studi shown close relationship occurr ira prognosi present studi attempt establish whether occurr ira use anti pd antibodi associ treatment efficaci peopl advanc gastric cancer agc
|
D000074322;D013274;D064420
|
T129;T121;T116;T191;T037;T046
|
36,335,319
|
sequenti mix method evalu accept feasibl appropri cognit behavior therapi psychosi step care cognit behavior therapi psychosi cbtp recommend nation treatment guidelin yet remain wide inaccess us step care model favor feasibl scarc intervent may improv access cbtp
|
D011618;D015928
|
T061;T048
|
36,335,318
|
characterist popul structur antimicrobi resist virul factor morpholog methicillin resist macrococcus caseolyticus global clade macrococcus caseolyticus opportunist pathogen frequent isol dairi product veterinari infect recent studi report possibl methicillin resist transfer among staphylococc speci food present studi examin popul structur antimicrobi resist virul factor morpholog methicillin resist caseolyticus investig genom deriv isol beef n pork n shanghai deposit public domain n phylogenet caseolyticus divid four clade consist genom isol contin european countri n asian countri n unit state n australia n sudan n caseolyticus isol present studi form genet distinguish clade character novel allel tradit gene mlst scheme furthermor identifi amr gene associ class antimicrobi agent caseolyticus amr gene carri domin plasmid repa rep repus genom global clade carri signific less amr gene p virul factor p present clade virul factor detect methicillin resist caseolyticus includ gene code hemolysin adher biofilm format exotoxin capsul associ human health infect final close relat genus staphylococcus scan electron microscopi sem transmiss electron microscopi tem perform morpholog comparison caseolyticus larger diamet thicker cell wall compar aureus atcc taken togeth studi suggest caseolyticus mediat diverg antimicrobi resist virul factor could serv vector methicillin resist habitat foodborn microorgan
|
D013203;D055624
|
T047;T007
|
36,335,317
|
hmga identifi key enhanc driver associ dna damag repair oral squamous cell carcinoma oral squamous cell carcinoma oscc main type oral cancer disturb dna repair invalu way improv effect tumor treatment aim explor key enhanc driver associ dna damag repair oscc cell
|
D009062;D002294;D006258
|
T191
|
36,335,316
|
combin atezolizumab nab paclitaxel treatment tripl negat breast cancer meta analysi efficaci safeti tripl negat breast cancer tnbc clinic aggress breast cancer poor prognosi approxim tnbc found express program death ligand pd l make potenti therapeut target pd l inhibitor atezolizumab recent approv immunotherapeut drug tnbc meta analysi aim review random control trial studi rcts combin atezolizumab nab paclitaxel treatment tnbc synthes evid base result effect safeti
|
D000971;D064726
|
T061;T191
|
36,335,315
|
real world data brief review method applic challeng opportun increas adopt internet social media wearabl devic e health servic technolog driven servic medicin healthcar led rapid generat various type digit data provid valuabl data sourc beyond confin tradit clinic trial epidemiolog studi lab base experi
|
D003695;D016247
|
T093;T062;T077;T170;T058;T169;T057
|
36,335,314
|
multimod ultrasound preoper evalu dermatofibrosarcoma protuberan seri case dermatofibrosarcoma protuberan dfsp rare low intermedi grade sarcoma need imag examin small seri ultrasound find dfsp publish howev use elastographi contrast enhanc ultrasound ceus dfsp studi aim studi multimod ultrasound find report correl imag tini extens dfsp preoper evalu
|
D018223;D012878
|
T191
|
36,335,313
|
vascular adhes protein express reduc intestin infant necrot enterocol observ research studi necrot enterocol nec inflammatori bowel diseas preterm neonat high morbid mortal treatment avail support broad spectrum antibiot gastrointestin rest better understand pathogenesi crucial develop new therapi vascular adhes protein vap express human blood vessel lymphat play crucial role pathogenesi inflammatori diseas adult aim studi investig vap express intestin infant affect nec
|
D020345;D007232
|
T047
|
36,335,312
|
appli ps social market retain engag particip longitudin cohort studi generat rain studi particip perspect investig particip retent longitudin health medic research document strategi work best overlook social market capac influenc particip retent appli social market framework idea determin longitudin particip buy product cost price locat place communic channel promot paper aim inform enhanc retent effort
|
D040241;D010290
|
T099;T102;T057
|
36,335,311
|
effect vitamin supplement oxid stress inflammatori biomark pregnant women systemat review meta analysi clinic trial vitamin defici common problem among pregnant women link matern inflamm oxid stress consequ advers pregnanc outcom aim systemat review evalu effect vitamin supplement oxid stress inflammatori biomark pregnant women accord prisma guidanc
|
D002097;D019587
|
T061;T129;T168;T116
|
36,335,310
|
preval thyroid nodul characterist thyroid ultrasound children goiter singl center experi goiter common present sign various thyroid diseas children thyroid nodul clinic andor radiolog signific find due high malign rate ultrasound us characterist pediatr patient goiter rare report literatur thus purpos studi assess characterist thyroid us preval thyroid nodul pediatr patient goiter
|
D016606;D006042
|
T047;T191
|
36,335,309
|
rs singl nucleotid polymorph increas sweet intak risk sever earli childhood cari case control studi dental cari one preval chronic diseas worldwid among children rs singl nucleotid polymorph snp sweet receptor gene tasr associ dental cari high risk perman teeth among school children adult date littl known associ snp sweet intak cari risk primari school children
|
D003731
|
T033;T047
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.